Evidências da eficácia de um método de biorressonância na cessação do tabagismo:um estudo piloto
Pihtili A.a · Galle M.b · Cuhadaroglu C.c · Kilicaslan Z.a · Issever H.d · Erkan F.a · Cagatay T.a · Gulbaran Z.a
Keywords: Bioresonance therapyDouble-blindMORA therapyPlacebo therapySmoking cessation
Forsch Komplementmed 2014;21:239-245
https://doi.org/10.1159/000365742
Complementary Medicine Research
Original Article · Originalarbeit
Introdução: Desde a década de 1970, a terapia de biorressonância MORA tem sido aplicada globalmente no contexto da medicina complementar para várias indicações. A este respeito, os profissionais também relatam uma aplicação bem-sucedida na cessação do tabagismo. O presente estudo tem como objetivo verificar esses relatos em um ambiente de estudo controlado. Métodos: Para atingir o objetivo supracitado, submetemos o método de biorressonância a um estudo prospectivo, controlado por placebo, duplo-cego, de grupo paralelo, envolvendo 190 fumantes. Em ambos os grupos de estudo (placebo n = 95; grupo de biorressonância ativa; n = 95), o curso do tratamento e as condições do estudo foram padronizados. Resultados: 1 semana (77,2% vs. 54,8%), 2 semanas (62,4% vs. 34,4%), 1 mês (51,1% vs. 28,6%) e 1 ano (28,6% vs. 16,1%) após o tratamento, a taxa de sucesso no grupo verum diferiu significativamente dos resultados no grupo placebo. Além disso, a condição de saúde subjetiva após o tratamento e a avaliação subjetiva da eficácia, pesquisadas após 1 semana, foram significativamente mais positivas entre os participantes do grupo de terapia de biorressonância ativa do que entre aqueles no grupo placebo. Não foram observados efeitos secundários adversos. Conclusão: De acordo com os achados alcançados por este estudo piloto, a terapia de biorressonância é clinicamente eficaz na cessação do tabagismo e não mostra efeitos colaterais adversos© 2014 S. Karger GmbH, Freiburg
References
1. Morell F: MORA-Therapie - patienteneigene und Farblichtschwingungen. Heidelberg, Haug, 1987.
2. Maiko OJ, Gogoleva EF: Outpatient bioresonance treatment of gonarthrosis (in Russian). Ter Arkh 2000;72:50-53.
External Resources
3. Gogoleva EF: New approaches to diagnosis and treatment of fibromyalgia in spinal osteochondrosis (in Russian). Ter Arkh 2001;73:40-45.
External Resources
4. Yang J, Zhang L: 300 Behandlungsbeispiele gegen Asthma mittels BICOM-Gerätes für die Kinderpatienten (in Chinese). Maternal and Child Health Care of China 2004;19:126-127.
5. Huang S, Sun Z, Fang Y: Klinische Behandlung vom allergischen Schnupfen und Bronchialasthma der Kinder mit dem Bioresonanztherapiegerät (in Chinese). Zhejiang Medical Journal 2005;27:457-458.
6. Nienhaus J, Galle M: Placebokontrollierte Studiezur Wirkung einer standardisierten MORA Bioresonanztherapie auf funktionelle Magen-Darm-Beschwerden. Forsch Komplementmed 2006;13:28-34.
External Resources
7. Schuller J, Galle M: Untersuchung zur Prüfung der klinischen Wirksamkeit elektronisch abgespeicherter Zahn- und Gelenksnosoden bei Erkrankungen des rheumatischen Formenkreises. Forsch Komplementärmed 2007;14:289-296.
External Resources
8. Rahlfs VW, Rozehnal A: Wirksamkeit und Verträglichkeit der Bioresonanzbehandlung. EHK 2008;57: 462-468.
External Resources
9. Chen T, Guo ZP, Zhang YH, Gao Y: Effect of MORA bioresonance therapy in the treatment of Henoch-Schonlein purpura and influence on serum antioxidant enzymes. J Clin Derm 2010;39:283-285.
10. Herrmann E, Galle M: Retrospective surgery study of the therapeutic effectiveness of MORA bioresonance therapy with conventional therapy resistant patients suffering from allergies, pain and infection diseases. Eur J Integr Med 2011;3:e237-e244.
External Resources
11. Liu L-L, Wan K-S, Cheng C-F, Tsai M-H, Wu Y-L, Wu W-F: Effectiveness of MORA electronic homeopathic copies of remedies for allergic rhinitis: a short-term, randomized, placebo-controlled PILOT study. Eur J Integr Med 2013;5:119-125.
External Resources
12. Hutzschenreuter P, Brümmer H: Die Narbe, das Keloid und die MORA-Therapie. Therapeutikon 1991;5:507-515.
13. Endler PC, Pongratz W, Smith CW, Schulte J: Non-molecular information transfer from thyroxine to frogs. Vet Human Toxicol 1995;37:259-263.
External Resources
14. Benveniste J, Aissa J, Guillonnet D: Digital biology: specificity of the digitized molecular signal. FASEB J 1998;12:A412.
15. Fedorowski A, Steciwko A, Rabczynski J: Low-frequency electromagnetic stimulation may lead to regression of Morris hepatoma in buffalo rats. J Altern Complement Med 2004;10:251-260.
External Resources
16. Thomas Y, Schiff M, Belkadi L, Jurgens P, Kahhak L, Benveniste J: Activation of human neutrophils by electronically transmitted phorbolmyristate acetate. Med Hypotheses 2000;54:33-39.
External Resources
17. Podcernyaeva RJ, Lopatina OA, Mikhailova GR, Baklanova OV, Danlibaeva GA, Gushina EA: Effect of exogenous frequency exposure on human cells. Bull Exp Biol Med 2008;146:148-152.
External Resources
18. Korenbaum VI, Chernysheva TN, Apukthina TP, Sovetnikova LN: Absorption spectra of electronic-homoeopathic copies of homoeopathic nosodes and placebo have essential differences. Forsch Komplementmed 2006;13:294-297.
External Resources
19. Montagnier L, Aissa J, Ferris S, Montagnier J-J, Lavallee C: Electromagnetic signals are produced by aqueous nanostructures derived from bacterial DNA sequences. Interdiscip Sci 2009;1:81-90.
External Resources
20. Schöni MH, Nikolaizik WH, Schöni-Affolter F: Efficacy trial of bioresonance in children with atopic dermatitis. Int Arch Allergy Immunol 1997;112:238-246.
External Resources
21. Kofler H, Ulmer H, Mechtler E, Falk M, Fritsch PO: Bioresonanz bei Pollinose - eine vergleichende Untersuchung zur diagnostischen und therapeutischen Wertigkeit. Allergologie 1996;19:114-122.
22. Wüthrich B, Frei PC, Bircher A, et al.: Bioresonanz - diagnostischer und therapeutischer Unsinn. Akt Dermatol 2006;32:79-77.
External Resources
23. Kleine-Tebbe J, Ballmer-Weber B, Beyer K, et al.: In-vitro-Diagnostik und molekulare Grundlagen von IgE-vermittelten Nahrungsallergien. Allergo J 2009;18:132-146.
24. Yorgancioglu A, Esen A: Nicotine dependence and physicians (in Turkish). Toraks Journal 2000;1:90-95.
25. Öztuna F: Treatment and follow-up in the smoking cessation polyclinic: review (in Turkish). Turkiye Klinikleri J Med Sci 2005;25:546-550.
26. White AR, Rampes H, Ernst E: Acupuncture for smoking cessation. Cochrane Database Syst Rev 2002;CD000009.
External Resources
27. White AR, Rampes H, Campbell JL: Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev 2006;CD000009.
External Resources
28. White AR, Rampes H, Liu JP, Stead LF, Campbell J: Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev 2011; CD000009.
External Resources
29. Abbot NC, Stead LF, White AR, Barnes J, Ernst E: Hypnotherapy for smoking cessation. Cochrane Database Syst Rev 2000;CD001008.
External Resources
30. Astrid Becerra N, Alba LH, Castillo JS, Murillo R, Carias A, Garcia-Herreias P: Alternative therapies for smoking cessation: clinical practice guidelines review. Gac Med Mex 2012;148:457-466.
External Resources
31. Isik ES: MORA bioresonance method (MORA-Therapy) to quit smoking. Clinical report 2011. Clinic Neosante, Istanbul, Turkey.
32. Fagerstrom KO, Schneider NG: Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 1989;12:159-182.
External Resources
33. Sachs L: Angewandte Statistik. Berlin, Springer, 1997.
External Resources
34. Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, Anziano R, Reeves K: Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med 2006;166:1571-1577.
External Resources
35. Jorenby DE, Hays JT, Rigotti NA, et al.: Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006;296:56-63.
External Resources
36. Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR; Varenicline Phase 3 Study Group: Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA 2006;296:64-71.
External Resources
37. Cahill K, Stead LF, Lancaster T: Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2007;CD006103.
External Resources
38. Gonzales D, Rennard SI, Nides M, et al.: Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 2006;296:47-55.
External Resources
39. Eisenberg MJ, Filion KB, Yavin D, et al.: Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ 2008;179:135-144.
External Resources
40. Fritz DJ, Corney RM, Steinmeyer B, Ditsan G, Hill N, Zee-Cheng J: The efficacy of auriculotherapy for smoking cessation: a randomized, placebo-controlled trial. J Am Board Fem Med 2013;26:61-70.
External Resources
41. Zhang AL, Di YM, Worsnop C, May BH, Xue CC: Ear acupressure for smoking cessation: study protocol for a randomized controlled trial. Forsch Komplementmed 2013;20:290-294.
External Resources
42. Riegel B: Hypnosis for smoking cessation: group and individual treatment - a free choice study. Int J Clin Exp Hypn 2013;61:146-161.
External Resources